| Richard S Legro, MD | |
|
35 Hope Drive, Stes 202/204, Hershey, PA 17033-2086 | |
| (717) 531-3503 | |
| (717) 531-4375 |
| Full Name | Richard S Legro |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 37 Years |
| Location | 35 Hope Drive, Hershey, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235193863 | NPI | - | NPPES |
| 0014142900004 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | MD044737E (Pennsylvania) | Secondary |
| 207VE0102X | Obstetrics & Gynecology - Reproductive Endocrinology | MD044737E (Pennsylvania) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Milton S Hershey Medical Center Physicians Group | 3870405483 | 1400 |
News Archive
Researchers at Brown Medical School and Rhode Island Hospital have shed new light on the activation of a protein key to the development of cancers, particularly breast and prostate cancer, the most commonly diagnosed cancers in the United States.
The prevalence of prescription opioid use increased from 4.1% of US adults in 1999-2000 to 6.8% in 2013-2014, according to a recent Pharmacoepidemiology and Drug Safety study.
Some people who have problems reading quickly appear to have abnormalities in the white matter of their brains, according to research published in the December 4, 2007, issue of Neurology®, the medical journal of the American Academy of Neurology.
In a new study, Danilo Perrotti and colleagues from Ohio State University, Columbus, show that treatment with a drug known as FTY720 prevents disease in a mouse model of many leukemias caused by the cancer protein BCR-ABL (nearly all cases of blast crisis chronic myeloid leukemia [CML-BC] and some cases of acute lymphocytic leukemia [ALL]).
› Verified 7 days ago
| Entity Name | The Milton S Hershey Medical Center Physicians Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710951744 PECOS PAC ID: 3870405483 Enrollment ID: O20040225000741 |
News Archive
Researchers at Brown Medical School and Rhode Island Hospital have shed new light on the activation of a protein key to the development of cancers, particularly breast and prostate cancer, the most commonly diagnosed cancers in the United States.
The prevalence of prescription opioid use increased from 4.1% of US adults in 1999-2000 to 6.8% in 2013-2014, according to a recent Pharmacoepidemiology and Drug Safety study.
Some people who have problems reading quickly appear to have abnormalities in the white matter of their brains, according to research published in the December 4, 2007, issue of Neurology®, the medical journal of the American Academy of Neurology.
In a new study, Danilo Perrotti and colleagues from Ohio State University, Columbus, show that treatment with a drug known as FTY720 prevents disease in a mouse model of many leukemias caused by the cancer protein BCR-ABL (nearly all cases of blast crisis chronic myeloid leukemia [CML-BC] and some cases of acute lymphocytic leukemia [ALL]).
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Richard S Legro, MD Po Box 858, Mc A410, Hershey, PA 17033-0858 Ph: (800) 243-1455 | Richard S Legro, MD 35 Hope Drive, Stes 202/204, Hershey, PA 17033-2086 Ph: (717) 531-3503 |
News Archive
Researchers at Brown Medical School and Rhode Island Hospital have shed new light on the activation of a protein key to the development of cancers, particularly breast and prostate cancer, the most commonly diagnosed cancers in the United States.
The prevalence of prescription opioid use increased from 4.1% of US adults in 1999-2000 to 6.8% in 2013-2014, according to a recent Pharmacoepidemiology and Drug Safety study.
Some people who have problems reading quickly appear to have abnormalities in the white matter of their brains, according to research published in the December 4, 2007, issue of Neurology®, the medical journal of the American Academy of Neurology.
In a new study, Danilo Perrotti and colleagues from Ohio State University, Columbus, show that treatment with a drug known as FTY720 prevents disease in a mouse model of many leukemias caused by the cancer protein BCR-ABL (nearly all cases of blast crisis chronic myeloid leukemia [CML-BC] and some cases of acute lymphocytic leukemia [ALL]).
› Verified 7 days ago
Kristin A Riley, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 35 Hope Dr Ste 202204, Hershey, PA 17033 Phone: 717-531-3503 Fax: 717-531-4375 | |
Irina Kostova Dimitrova, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 500 University Dr, Hershey, PA 17033 Phone: 717-531-6585 | |
Rebecca Phaeton, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 500 University Dr, Hershey, PA 17033 Phone: 800-243-1455 | |
William M Curtin, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 500 University Dr, Hershey, PA 17033 Phone: 800-243-1455 Fax: 717-531-7269 | |
Rae L Kennedy, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 670 Cherry Dr, Ste 202/204, Hershey, PA 17033 Phone: 800-233-4082 | |
Richard C Pees, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 670 Cherry Dr, Ste 202/204, Hershey, PA 17033 Phone: 800-233-4082 | |
Jaimie Maines, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 500 University Dr, Hershey, PA 17033 Phone: 717-531-8521 |